Clinical Trials Logo
  1. Home
  2. HIV Infections
  3. NCT00137644
  4. Details
NCT00137644 Clinical Trial

Evaluation of the Preventing AIDS Through Live Movement and Sound (PALMS) Intervention for Minority Adolescents

HIV Infections Clinical Trial

Official title:
Evaluation of the Preventing AIDS Through Live Movement and Sound (PALMS) Innovative HIV Prevention Intervention for Minority Adolescents by the Philadelphia Health Management Corporation in Philadelphia, PA

Clinical Trial Details — Status: Completed

Administrative data
NCT number NCT00137644
Other study ID # CDC-NCHSTP-CCU324516
Secondary ID U65/CCU324516
Status Completed
Phase Phase 1/Phase 2
First received August 26, 2005
Last updated January 6, 2010
Start date March 2005
Est. completion date January 2007

Study information
Verified date January 2010
Source Centers for Disease Control and Prevention
Contact n/a
Is FDA regulated No
Health authority United States: Federal Government
Study type Interventional

Clinical Trial Summary

The purpose of this program evaluation is to determine whether the Preventing AIDS Through Live Movement and Sound (PALMS) group-level intervention is effective in reducing HIV sex risk behaviors and increasing HIV testing of high-risk, incarcerated or adjudicated youth. The intent of this program is to support the evaluation of an existing intervention and provide feedback to the implementing organization for improved program effectiveness, not to conduct research.

Description:

Philadelphia Health Management Corporation (PHMC) is evaluating the Preventing AIDS Through Live Movement and Sound (PALMS) group-level intervention for high-risk, incarcerated or adjudicated youth. PALMS uses three theater-based sessions to increase knowledge about HIV/AIDS, increase HIV testing, and reduce risky sexual behavior through increased self-efficacy. The intervention is delivered by peers, and peers work with the intervention team to use evaluation results to improve the program. The evaluation will recruit male adolescents, aged 12 to 18 years, who are residing in juvenile justice or drug treatment facilities in Philadelphia. The evaluation design uses concurrent intervention (N=132) and comparison (N=132) groups. Data will be collected at baseline, immediate post-intervention, and at a 6-month post-intervention follow-up. The intent of this program is to support the evaluation of an existing intervention and provide feedback to the implementing organization for improved program effectiveness, not to conduct research.

Recruitment information / eligibility
Status Completed
Enrollment 264
Est. completion date January 2007
Est. primary completion date
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Male
Age group 12 Years to 18 Years
Eligibility Inclusion Criteria:

- Male adolescents

- Between the ages of 12 and 18

- Receiving residential services at juvenile justice or drug treatment facilities

- African-American or Latino

Exclusion Criteria:

- Do not speak English

- Prior participation in PALMS intervention

- Female adolescents

Study Design

Allocation: Non-Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Prevention

Related Conditions & MeSH terms

Intervention

Behavioral:
• Preventing AIDS Through Live Movement and Sound (PALMS)

Locations
Country Name City State
United States Philadelphia Health Management Corporation Philadelphia Pennsylvania

Sponsors (2)
Lead Sponsor Collaborator
Centers for Disease Control and Prevention Public Health Management Corporation

Country where clinical trial is conducted

United States, 

Outcome
Type Measure Description Time frame Safety issue
Primary Sexual activity Within past 3 months & ever
Primary Number and type (main and non-main) of female sex partners Within past 3 months
Primary Frequency of condom use with female sex partners Within past 3 months
Primary HIV testing (ever tested, number of tests, likelihood of test) Within past 3 months
Secondary Drug use Within past 3 months
Secondary Knowledge of HIV transmission, prevention and testing Concurrent
Secondary Attitudes and beliefs about condoms and safe sex Concurrent
Secondary Beliefs about HIV and HIV testing Concurrent
Secondary Perception of HIV risk concurrent
Secondary Self-efficacy to use condoms and practice safe sex Concurrent
Secondary Self-esteem Concurrent
Secondary Perceptions of cultural and peer norms Concurrent
See also
  Status Clinical Trial Phase
Completed NCT05454514 - Automated Medication Platform With Video Observation and Facial Recognition to Improve Adherence to Antiretroviral Therapy in Patients With HIV/AIDS N/A
Completed NCT03760458 - The Pharmacokinetics, Safety, and Tolerability of Abacavir/Dolutegravir/Lamivudine Dispersible and Immediate Release Tablets in HIV-1-Infected Children Less Than 12 Years of Age Phase 1/Phase 2
Completed NCT03067285 - A Phase IV, Open-label, Randomised, Pilot Clinical Trial Designed to Evaluate the Potential Neurotoxicity of Dolutegravir/Lamivudine/Abacavir in Neurosymptomatic HIV Patients and Its Reversibility After Switching to Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide. DREAM Study Phase 4
Completed NCT03141918 - Effect of Supplementation of Bioactive Compounds on the Energy Metabolism of People Living With HIV / AIDS N/A
Recruiting NCT04579146 - Coronary Artery Disease (CAD) in Patients HIV-infected
Completed NCT06212531 - Papuan Indigenous Model of Male Circumcision N/A
Active, not recruiting NCT03256422 - Antiretroviral Treatment Taken 4 Days Per Week Versus Continuous Therapy 7/7 Days Per Week in HIV-1 Infected Patients Phase 3
Completed NCT03256435 - Retention in PrEP Care for African American MSM in Mississippi N/A
Completed NCT00517803 - Micronutrient Supplemented Probiotic Yogurt for HIV/AIDS and Other Immunodeficiencies N/A
Active, not recruiting NCT03572335 - Systems Biology of Diffusion Impairment in Human Immunodeficiency Virus (HIV)
Completed NCT04165200 - Fecal Microbiota Transplantation as a Therapeutic Strategy for Patients Infected With HIV N/A
Recruiting NCT03854630 - Hepatitis B Virus Vaccination in HIV-positive Patients and Individuals at High Risk for HIV Infection Phase 4
Terminated NCT03275571 - HIV, Computerized Depression Therapy & Cognition N/A
Completed NCT02234882 - Study on Pharmacokinetics Phase 1
Completed NCT01618305 - Evaluating the Response to Two Antiretroviral Medication Regimens in HIV-Infected Pregnant Women, Who Begin Antiretroviral Therapy Between 20 and 36 Weeks of Pregnancy, for the Prevention of Mother-to-Child Transmission Phase 4
Recruiting NCT05043129 - Safety and Immune Response of COVID-19 Vaccination in Patients With HIV Infection
Not yet recruiting NCT05536466 - The Influence of Having Bariatric Surgery on the Pharmacokinetics, Safety and Efficacy of the Novel Non-nucleoside Reverse Transcriptase Inhibitor Doravirine N/A
Recruiting NCT04985760 - Evaluation of Trimer 4571 Therapeutic Vaccination in Adults Living With HIV on Suppressive Antiretroviral Therapy Phase 1
Completed NCT05916989 - Stimulant Use and Methylation in HIV
Terminated NCT02116660 - Evaluation of Renal Function, Efficacy, and Safety When Switching From Tenofovir/Emtricitabine Plus a Protease Inhibitor/Ritonavir, to a Combination of Raltegravir (MK-0518) Plus Nevirapine Plus Lamivudine in HIV-1 Participants With Suppressed Viremia and Impaired Renal Function (MK-0518-284) Phase 2

External Links